Native Meta creative and exact outbound link observed October 22, 2026. Redirects were followed to the captured public destination. Advertiser claims are source material; activity does not establish performance. No personal, health or payment details were entered.

A longer-term offer leads through customer stories, treatment education, care steps and purchase entry. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
The price is the whole ad, and it's impossible to miss: $149/MO in huge yellow type with the if-approved qualifier directly under it. The row of vials quietly signals a longer supply without needing a word of explanation. The two supporting lines answer where the medication comes from and what comes with it, and the fine print states the six-month minimum and the $894 renewal every 22 weeks plainly.
The ad doesn't say why the price is lower. Anyone who's seen Brello's $166 offers won't know $149 is tied to a longer commitment until the fine print, and anyone new has no reason to choose six months over three. There's no problem named and no proof on the frame either. Put the two prices side by side ($149 on six months against $166 on three) so the trade is the message, and add the Trustpilot badge Brello uses on other statics.
Several vials suggest a longer supply before the viewer reads the terms.
Leading with a price below the $166 Brello quotes elsewhere makes the number itself the hook.
These answer where the product comes from and what's included in one glance.
It states the commitment behind the lower monthly figure.
Tirzepatide at $149/month (if approved) on a six-month plan minimum that automatically renews for $894 every 22 weeks until cancelled.
The ad sends people to tirzepatide6monthplan.brellohealth.com, a dedicated offer page for the longer plan rather than the homepage or a quiz. The match is close: the plan offer hero is headlined New! 6-Month Tirzepatide Plan $149/month special, the six-month option is preselected with a Best value badge and a crossed-out $1,788 anchor, and the three-month plan sits right under it for comparison. That's exactly the side-by-side choice the ad itself is missing, and a shipping note explains the plan arrives in two shipments, which answers a question a longer plan raises.
Brello's six-month Tirzepatide page is a dedicated offer page for a $149 a month plan. Its hero lets visitors choose between the preselected six-month plan and the three-month plan, then the page moves through reviews, treatment education, a care path, inclusions and FAQs. It's where one Brello ad in the library lands, a $149 price-led static.
A price lock banner and a New! 6-Month Tirzepatide Plan headline at $149 a month, with a plan picker comparing six months and three months, answering which plan to choose and what each costs.
A Trustpilot rating based on 4,000+ reviews and four review cards about community, customer service and members' own experiences, answering whether others have done this.
A deeper look inside Tirzepatide with a short explanation, what studies examine, footnotes and a results-may-vary note, answering what the medication is.
A straightforward path to care in four photo steps with a Start Your Journey button, answering how the process works after you choose a plan.
What makes Brello different, with six inclusions beside a photo and a Take the First Step button, answering what you get beyond the medication.
Questions on approval, refunds, inclusions and timelines plus the disclaimers and plan terms, answering the last practical doubts.
Read the full breakdown of this page
One of 22 Brello Health ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.